Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations were updated to add several new sites (Colorado, Georgia, Ceará, Paraná, Rio Grande do Sul, Santa Catarina, São Paulo, Alberta, Ontario, Quebec, Jihormoravsky KRAJ, Prague, Hajdú-Bihar, West Pomeranian Voivodeship, England, Surrey). It also removes previously listed sites, altering where the study is conducted and how to contact investigators.SummaryDifference1.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe PubMed publication text on the study page was updated to indicate publications are automatically filled from PubMed, and the revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the government funding status notice that warned about potential delays and directed users to update sources for operating status.SummaryDifference0.2%

- Check66 days agoChange DetectedThe update appears to reflect only minor UI/layout changes with no alterations to core study content (title, BRCA mutation, interventions, outcomes, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference2%

- Check94 days agoChange DetectedPage version updated to v3.1.0; removal of the term 'Ovarian cancer'.SummaryDifference0.1%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.